Quark Biotech, Inc. is a U.S. based biopharmaceutical company, focused on the development of drugs for unmet medical needs. Based on the proprietary targets identified using our enabling foundation technology, BiFAR, we are developing antibodies, siRNA based therapeutics and small molecules potentially applicable to several diseases. Our most advanced product, the small molecule BT16, is in clinical phase II for dyslipidemia.